ARTICLE SUMMARY:
Polycystic Ovary Syndrome (PCOS) is the leading cause of female infertility and the most frequently occurring endocrine disorder in women. AblaCare, a recent addition to medtech accelerator MD Start‘s portfolio of therapeutic device companies, is introducing a new device that treats PCOS infertility using RF ablation technology to replicate the effects of laparoscopic ovarian drilling with a safer and less invasive, office-based procedure.
Infertility in women can be a devastating condition that profoundly affects countless lives.
